Kurma Partners

Kurma Partners is a Paris-based management company founded in 2009 that focuses on financing innovation in healthcare and biotechnology. It specializes in supporting therapeutic and medical advancements from pre-creation stages to development capital. The firm is recognized as a significant player in the European market, actively investing in sectors such as life sciences, health technology, pharmaceuticals, and digital health. Kurma Partners collaborates with various prestigious research institutions and hospitals to foster innovation and growth in these fields.

Benjamin Belot

Partner

Hadrien Bouchez

Associate

Sylvain Cascarino

CFO

Rémi Droller

Managing Partner

Alain Horvais

Partner

Thierry Laugel

Managing Partner

Vanessa Malier

Managing Partner

Daniel Parera

Partner, Growth Opportunities

Philippe Peltier

Partner

Ségolène Perin

Analyst

Arnaud Pradier

Partner, AgrifoodTech

Jean-Francois Rivassou

Partner

Katrien Swerts

Partner, AgrifoodTech

Past deals in Children

Poppins

Venture Round in 2025
Poppins merges music, technology, and neuroscience to reshape therapy into a musical experience. We create musical games for children based on neurologic music therapy methods. These games are designed to address learning dissabilities like dyslexia, providing a digital treatment at home and helping identify these conditions. Behind these games, we leverage data science and new technologies to interpret learning, language, and motor performance into a cognitive score. Our goal is to improve the process for patients receiving treatment and to reaching the vast undiagnosed majority.

Poppins

Venture Round in 2023
Poppins merges music, technology, and neuroscience to reshape therapy into a musical experience. We create musical games for children based on neurologic music therapy methods. These games are designed to address learning dissabilities like dyslexia, providing a digital treatment at home and helping identify these conditions. Behind these games, we leverage data science and new technologies to interpret learning, language, and motor performance into a cognitive score. Our goal is to improve the process for patients receiving treatment and to reaching the vast undiagnosed majority.

Poppins

Seed Round in 2021
Poppins merges music, technology, and neuroscience to reshape therapy into a musical experience. We create musical games for children based on neurologic music therapy methods. These games are designed to address learning dissabilities like dyslexia, providing a digital treatment at home and helping identify these conditions. Behind these games, we leverage data science and new technologies to interpret learning, language, and motor performance into a cognitive score. Our goal is to improve the process for patients receiving treatment and to reaching the vast undiagnosed majority.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.